Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HS-20094

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Regeneron · Phase 2 · Recruiting · Enrollment 360

NCT07685808

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Olatorepatide arm 1n/rn/rn/rn/r
Olatorepatide arm 2n/rn/rn/rn/r
Olatorepatide arm 3n/rn/rn/rn/r
Olatorepatide arm 4n/rn/rn/rn/r
Olatorepatide arm 5n/rn/rn/rn/r
Matching Placebo arm 6n/rn/rn/rn/r

Not shown

  • Olatorepatide arm 1: endpoint not reported
  • Olatorepatide arm 2: endpoint not reported
  • Olatorepatide arm 3: endpoint not reported
  • Olatorepatide arm 4: endpoint not reported
  • Olatorepatide arm 5: endpoint not reported
  • Matching Placebo arm 6: endpoint not reported